Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
(17 sites) China
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Peking Union Medical College Hospital, Beijing Peking University First Hospital, Beijing Beijing Hospital of Ministry of Health, Beijing Xiangya Hospital Central South University, Changsha West China Hospital of Sichuan University, Chengdu The First Affiliated Hospital, Chongqing Medical University, Chongqing The First Affiliated Hospital of Sun Yat-sen University, Guangzhou The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou Inner Mongolia Autonomous Region People's Hospital, Hohhot Lanzhou University Second Hospital, Lanzhou The First Hospital of China Medical University, Shenyang The Second Hospital of Hebei Medical University, Shijiazhuang 1st Affiliated Hospital of Shanxi Medical University, Taiyuan Xinjiang People Hospital, Ürümqi Tongji Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan